EXMceuticals Inc announced a best-efforts private placement of 40,000,000 units at CAD 0.15 per unit for gross proceeds of up to CAD 6,000,000 on March 3, 2021. Each unit will consist of one common share and and one half share purchase warrant. Each warrant will entitle the holder to purchase a share at an exercise price of CAD 0.25, at any time up to 24 months following the date of issuance; provided that if, at any time prior to the expiry date of the warrants, the volume weighted average trading price of the common shares on the Canadian Stock Exchange, or other principal exchange on which the shares are listed, is greater than CAD 0.50 for 10 consecutive trading days, the company may, within 10 business days of the occurrence of such event, deliver a notice to the holders of warrants accelerating the expiry date of the Warrants to the date that is 30 days following the date of such notice. Any unexercised Warrants will automatically expire at the end of the accelerated exercise period.